2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine. DMCPA was first synthesized by Alexander Shulgin. In his book '' PiHKAL'', the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours. DMCPA produces open-eye visuals,

anorexia Anorexia nervosa, often referred to simply as anorexia, is an eating disorder characterized by low weight, food restriction, body image disturbance, fear of gaining weight, and an overpowering desire to be thin. ''Anorexia'' is a term of Gre ...

, and psychedelic

dreams A dream is a succession of images, ideas, emotions, and sensations that usually occur involuntarily in the mind during certain stages of sleep. Humans spend about two hours dreaming per night, and each dream lasts around 5 to 20 minutes, althou ...

. Shulgin gives it a +++ on the

Shulgin Rating Scale The Shulgin Rating Scale (or "quantitative potency scale") is a simple scale for reporting the subjective effect of psychoactive substances at a given dosage, and at a given time. The system was developed for research purposes by the American bioche ...

Legality

United Kingdom

This substance is a Class A drug in the

Drugs controlled by the UK Misuse of Drugs Act These drugs are known in the UK as ''controlled drugs'', because this is the term by which the act itself refers to them. In more general terms, however, many of these drugs are also controlled by the Medicines Act 1968, there are many other drug ...

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.

References

{{DEFAULTSORT:Dimethoxy-4-methylphenylcyclopropylamine, 2,5- Psychedelic phenethylamines Cyclopropanes

Legality

United Kingdom

Pharmacology

See also

References